Shareholders of the French technology consultancy Altran voted in two new board nominees—Philippe Salle and Monique Cohen—setting the stage for the ouster of Chief Executive Yves de Chaisemartin, Reuters reported. Top shareholder Altrafin Participations, which is controlled by private equity firm Apax Partners, wants to replace Chaisemartin with Salle. The new board appointments gives Apax six out of 10 seats on the company’s board, enough to force a vote to replace Chaisemartin, Reuters wrote.

David M.V. Barnes will join investment bank Imperial Capital as a managing director and head of its financial sponsors coverage team in the bank’s LA office. Previously, Barnes had been with investment bank Houlihan Lokey.

Charles Costenbader will join Tangent Energy Solutions, the Pennsylvania-based on-site energy supply manager. Costenbader formerly worked with Macquarie Energy and GE Capital.

Michael Ducey has been named to the board of directors of Apollo Global Management, and also to the board’s audit and conflicts committee. Ducey was most recently with Compass Minerals International, where he served as president, chief executive and director. He retired from the company in May 2006. Earlier in his career, Ducey worked for nearly 30 years at Borden Chemical.

David Goldstein and Gerald Rokoff have joined the law firm DLA Piper as partners in its New York offices. Both formerly were with the firm White & Case. Goldstein joins the firm’s global finance group and will lead the investment funds practice. Rokoff joins the tax group.

Fisher Lynch Capital, a private equity funds-of-funds and co-investment manager, has added Kristie Goodman as director of investor relations and Dana O’Brien as director of administration and legal affairs. Both are newly created positions. Goodman joins from Parish Capital Advisors where she served as vice president of marketing and investor relations. O’Brien joins from MPM Capital in Boston, where she served as director of operations and legal affairs.

Matthew Hafter has joined the law firm Seyfarth Shaw as a partner in the firm’s Chicago office. Hafter joins from Grippo & Elden. In his new role, Hafter will focus across a broad range of transactions, including mergers and acquisitions, venture capital, public and private securities offerings and secured lending, the firm said in a statement.

Harris Williams & Co. has promoted 13 employees in its offices in London, Minneapolis and Richmond. Tim Alexander, James Clark, Derek Lewis, Patrick McNulty and Cheairs Porter have each been promoted to managing director. Joe Conner, Brian Lucas, Francois Morin, Chris Rogers and Geoff Smith have each been promoted to director. Jershon Jones, John Klim and Luke Semple have each been promoted to vice president.

Hercules Technology Growth Capital said it has added Paul Enderle, Chad Norman and Brad Pritchard as managing directors. Enderle joins the technology and lower middle market group in Hercules’s Boston office. Norman joins in Palo Alto, Calif., as a managing director in the life sciences group. Pritchard joins the cleantech group and will be based in Palo Alto.

Tom Kim has been promoted to principal at the Dallas-based middle market bank MHT Partners. Kim, formerly a management consultant at Boston Consulting Group, is focused on tech-enabled, educational, business services and consumer-focused companies.

Kenneth Lee, a principal at growth capital firm SAIF Partners, has joined the board of Sinovac Biotech Ltd. Sinovac is a provider of biopharmaceutical products in China. focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A and seasonal influenza.

The mid-market investment bank Lincoln International has opened a Moscow office, and appointed Andrei Joosten as the managing director who will lead the region comprising Russia, Ukraine, Belarus, Armenia, Azerbaijan, Kazakhstan, Uzbekistan, Kyrgyzstan, Moldova, Turkmenistan, and Tajikistan. Lincoln has 11 other offices around the world, including in Madrid, New York, and Paris. Joosten, who is fluent in Russian, English and Dutch, recently joined Lincoln from Deloitte and Touche, where he was a partner and head of M&A in the company’s Moscow office. He joined Deloitte in 2005.

Joseph Manko has joined Mufson Howe Hunter & Co. as a managing director. He will focus on infrastructure, alternative and renewable energy and environmental services at Mufson, a boutique investment bank. Manko previously was a partner and CEO of BZ Fund Management, of Switzerland.

Arlene Morris has joined the board of directors of Syndax Pharmaceuticals, the Massachusetts-based oncology company. Morris was most recently the CEO and board member of Affymax Inc., the biopharma company spun from GlaxoSmithKline. Among Syndax’s backers are Domain Associates, MPM Capital, Avalon, Pappas and Forward Ventures.

David Musicant has joined private equity investor American Securities as a senior director, the firm said. Musicant previously worked for BofA/Merrill Lynch, where he was a managing director and launched the bank’s middle market financial sponsor coverage effort. American Securities is based in New York.

As Nefab, a global, Sweden-based packaging company, looks toward a public listing within two years, its president and CEO, Stefan Ekqvist, will be leaving his post. At year end, Ekqvist will be replaced by David Mörk, who has worked for Nefab in various functions since 2000, most recently as regional manager for Asia. Nordic Capital owns the company together with the founding Nordgren/Pihl family, which jointly bought out the company from the Stockholm stock exchange in August 2007.

Kamal Tabet has joined Terra Firma as its new head of investor relations, Reuters reported. The former head of private equity at Citigroup, Tabet spent 14 years at Citigroup and was global head of the financial entrepreneurs group until January 2009, Reuters wrote.

Ernest Waaser has been appointed CEO and director at Systagenix Wound Management, a UK-based wound care provider. Steve Atkinson, the departing CEO, will continue to work with One Equity Partners as a consultant and adviser on medical device investments. One Equity counts Systagenix—formerly Johnson & Johnson’s wound care business—among its health care and medical device portfolio companies.